Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 2

Results: 11

Detection of piRNA‐54265 in human serum: evidence and significance.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 276, doi. 10.1002/cac2.12381
By:
- Mai, Dongmei;
- Ye, Ying;
- Zhuang, Lisha;
- Zheng, Jian;
- Lin, Dongxin
Publication type:
Article
Social‐epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 290, doi. 10.1002/cac2.12371
By:
- Song, Nan;
- Dong, Qian;
- Chen, Cheng;
- Li, Qian;
- Mulder, Heather;
- Plyler, Emily;
- Easton, John;
- Walker, Emily;
- Olson, Scott;
- Neale, Geoffrey;
- Krull, Kevin R.;
- Srivastava, Deo Kumar;
- Ness, Kirsten K.;
- Zhang, Jinghui;
- Hudson, Melissa M.;
- Robison, Leslie L.;
- Huang, I‐Chan;
- Wang, Zhaoming
Publication type:
Article
Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 285, doi. 10.1002/cac2.12369
By:
- Liu, Rui;
- Liu, Panpan;
- Bi, Huichang;
- Ling, Jianhua;
- Zhang, Huiqin;
- Zhang, Mingquan;
- Hu, Yumin;
- Chiao, Paul J;
- Huang, Peng;
- Liu, Jinyun
Publication type:
Article
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 257, doi. 10.1002/cac2.12399
By:
- Lin, Qing;
- Zheng, Shangyou;
- Yu, Xianjun;
- Chen, Meifu;
- Zhou, Yu;
- Zhou, Quanbo;
- Hu, Chonghui;
- Gu, Jing;
- Xu, Zhongdong;
- Wang, Lin;
- Liu, Yimin;
- Liu, Qingyu;
- Wang, Min;
- Li, Guolin;
- Cheng, He;
- Zhou, Dongkai;
- Liu, Guodong;
- Fu, Zhiqiang;
- Long, Yu;
- Li, Yixiong
Publication type:
Article
Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 171, doi. 10.1002/cac2.12400
By:
- Zou, Limin;
- Qi, Yueli;
- Jiang, Yongling;
- Tang, Ling;
- Du, Yu;
- Zhao, Boyuan;
- Sun, Yanzhe;
- Xiang, Meiyi;
- Ma, Jun;
- Yang, Zhimin
Publication type:
Article
Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 246, doi. 10.1002/cac2.12397
By:
- Zhao, Yuanyuan;
- Zhao, Bing;
- Chen, Gang;
- Chen, Yinlan;
- Liao, Zijun;
- Zhang, Haiming;
- Feng, Weineng;
- Li, Yinyin;
- Weng, Heng;
- Li, Weidong;
- Zhou, Yuefen;
- Ren, Biyong;
- Lu, Yanda;
- Chen, Jianhua;
- Liu, Zhenteng;
- Su, Zhenzhong;
- Wang, Wenliang;
- Zhang, Li
Publication type:
Article
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 214, doi. 10.1002/cac2.12396
By:
- Liu, Fei;
- Wang, Zixian;
- Li, Xiaofan;
- Zhang, Zhen;
- Yang, Yue;
- Chen, Junquan;
- Chen, Dinghua;
- Wu, Lingling;
- Liu, Xiangyu;
- Han, Sujun;
- Wang, Fangming;
- Wahafu, Wasilijiang;
- Gao, Yibo;
- Ren, Shancheng;
- Xing, Nianzeng;
- Cai, Guangyan;
- Chen, Xiangmei
Publication type:
Article
Elevated neutrophil extracellular traps by HBV‐mediated S100A9‐TLR4/RAGE‐ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 225, doi. 10.1002/cac2.12388
By:
- Zhan, Xi;
- Wu, Rui;
- Kong, Xue‐Hua;
- You, Yan;
- He, Kun;
- Sun, Xiao‐Yu;
- Huang, Yong;
- Chen, Wei‐Xian;
- Duan, Liang
Publication type:
Article
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 177, doi. 10.1002/cac2.12394
By:
- Ghaedrahmati, Farhoodeh;
- Esmaeil, Nafiseh;
- Abbaspour, Maryam
Publication type:
Article
Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 280, doi. 10.1002/cac2.12368
By:
- Chen, Zhiwei;
- Zhu, Peng;
- Liu, Zuojin;
- Zhu, Bin;
- Yin, Guobing;
- Ming, Jia;
- Song, Rui;
- Pan, Qingbo;
- Li, Tong;
- Jiang, Xingwei;
- Wang, Bing;
- Liu, Shuaibin;
- Cai, Hongxing;
- Wang, Jingjie;
- Han, Yuling;
- Lin, Zijing;
- Hong, Yang;
- Chen, Min;
- Peng, Mingli;
- Hu, Lina
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2023, v. 43, n. 2, p. 169, doi. 10.1002/cac2.12299
Publication type:
Article